Tabular List. Categories and Subcategories of ICD-10
Tabular List. Categories and Subcategories of ICD-10
Tabular List. Categories and Subcategories of ICD-10
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Tabular</strong> <strong>List</strong>. <strong>Categories</strong> <strong>and</strong> <strong>Subcategories</strong> <strong>of</strong> <strong>ICD</strong>-<strong>10</strong><br />
Y41.2 Adverse effects <strong>of</strong> antimalarials <strong>and</strong> drugs acting on other blood protozoa<br />
Y41.3 Adverse effects <strong>of</strong> other antiprotozoal drugs<br />
Y41.4 Adverse effects <strong>of</strong> anthelminthics<br />
Y41.5 Adverse effects <strong>of</strong> antiviral drugs<br />
Y41.8 Adverse effects <strong>of</strong> other specified systemic anti-infectives <strong>and</strong> antiparasitics<br />
Y41.9 Adverse effects <strong>of</strong> systemic anti-infective <strong>and</strong> antiparasitic, unspecified<br />
Y42 Adverse effects <strong>of</strong> hormones <strong>and</strong> their synthetic substitutes <strong>and</strong> antagonists, not elsewhere classified<br />
Y42.0 Adverse effects <strong>of</strong> glucocorticoids <strong>and</strong> synthetic analogues<br />
Y42.1 Adverse effects <strong>of</strong> thyroid hormones <strong>and</strong> substitutes<br />
Y42.2 Adverse effects <strong>of</strong> antithyroid drugs<br />
Y42.3 Adverse effects <strong>of</strong> insulin <strong>and</strong> oral hypoglycaemic [antidiabetic] drugs<br />
Y42.4 Adverse effects <strong>of</strong> oral contraceptives<br />
Y42.5 Adverse effects <strong>of</strong> other estrogens <strong>and</strong> progestogens<br />
Y42.6 Adverse effects <strong>of</strong> antigonadotrophins, antiestrogens, anti<strong>and</strong>rogens, not elsewhere classified<br />
Y42.7 Adverse effects <strong>of</strong> <strong>and</strong>rogens <strong>and</strong> anabolic congeners<br />
Y42.8 Adverse effects <strong>of</strong> other <strong>and</strong> unspecified hormones <strong>and</strong> their synthetic substitutes<br />
Y42.9 Adverse effects <strong>of</strong> other <strong>and</strong> unspecified hormone antagonists<br />
Y43 Adverse effects <strong>of</strong> primarily systemic agents<br />
Y43.0 Adverse effects <strong>of</strong> antiallergic <strong>and</strong> antiemetic drugs<br />
Y43.1 Adverse effects <strong>of</strong> antineoplastic antimetabolites<br />
Y43.2 Adverse effects <strong>of</strong> antineoplastic natural products<br />
Y43.3 Adverse effects <strong>of</strong> other antineoplastic drugs<br />
Y43.4 Adverse effects <strong>of</strong> immunosuppressive agents<br />
Y43.5 Adverse effects <strong>of</strong> acidifying <strong>and</strong> alkalizing agents<br />
Y43.6 Adverse effects <strong>of</strong> enzymes, not elsewhere classified<br />
Y43.8 Adverse effects <strong>of</strong> other primarily systemic agents, not elsewhere classified<br />
Y43.9 Adverse effects <strong>of</strong> primarily systemic agent, unspecified<br />
Y44 Adverse effects <strong>of</strong> agents primarily affecting blood constituents<br />
Y44.0 Adverse effects <strong>of</strong> iron preparations <strong>and</strong> other anti-hypochromic-anaemia preparations<br />
Y44.1 Adverse effects <strong>of</strong> vitamin B12, folic acid <strong>and</strong> other anti-megaloblastic- anaemia preparations<br />
Y44.2 Adverse effects <strong>of</strong> anticoagulants<br />
Y44.3 Adverse effects <strong>of</strong> anticoagulant antagonists, vitamin K <strong>and</strong> other coagulants<br />
Y44.4 Adverse effects <strong>of</strong> antithrombotic drugs [platelet-aggregation inhibitors]<br />
Y44.5 Adverse effects <strong>of</strong> thrombolytic drugs<br />
Y44.6 Adverse effects <strong>of</strong> natural blood <strong>and</strong> blood products<br />
Y44.7 Adverse effects <strong>of</strong> plasma substitutes<br />
Y44.9 Adverse effects <strong>of</strong> other <strong>and</strong> unspecified agents affecting blood constituents<br />
Y45 Adverse effects <strong>of</strong> analgesics, antipyretics <strong>and</strong> anti-inflammatory drugs<br />
Y45.0 Adverse effects <strong>of</strong> opioids <strong>and</strong> related analgesics<br />
Y45.1 Adverse effects <strong>of</strong> salicylates<br />
Y45.2 Adverse effects <strong>of</strong> propionic acid derivatives<br />
Y45.3 Adverse effects <strong>of</strong> other nonsteroidal anti-inflammatory drugs [NSAID]<br />
Y45.4 Adverse effects <strong>of</strong> antirheumatics<br />
Y45.5 Adverse effects <strong>of</strong> 4-aminophenol derivatives<br />
Y45.8 Adverse effects <strong>of</strong> other analgesics <strong>and</strong> antipyretics<br />
Y45.9 Adverse effects <strong>of</strong> analgesic, antipyretic <strong>and</strong> anti-inflammatory drug, unspecified<br />
Y46 Adverse effects <strong>of</strong> antiepileptics <strong>and</strong> antiparkinsonism drugs<br />
Y46.0 Adverse effects <strong>of</strong> succinimides<br />
Y46.1 Adverse effects <strong>of</strong> oxazolidinediones<br />
Y46.2 Adverse effects <strong>of</strong> hydantoin derivatives<br />
Y46.3 Adverse effects <strong>of</strong> deoxybarbiturates<br />
Y46.4 Adverse effects <strong>of</strong> iminostilbenes<br />
Y46.5 Adverse effects <strong>of</strong> valproic acid<br />
Y46.6 Adverse effects <strong>of</strong> other <strong>and</strong> unspecified antiepileptics<br />
253
Change language